Discover Xpert® Xpress Flu/RSV: Rapid, on-demand, best-in-class results everywhere this flu season. Detect it. Manage it.
What impact would rapid flu detection in 30 minutes have on your winter pressure strategy this year? Hear for yourself @ Infection Prevention 2019.
To learn more, visit Cepheid Booth #25 @ Infection Prevention 2019, or see http://info.cepheid.com/ips-uk-2019
In any healthcare environment, rapid, accurate diagnosis of influenza is vital for effective clinical management and infection control. Cepheid’s Xpert® Xpress Flu/RSV molecular diagnostic test, run on the GeneXpert® System, provides best-in-class, on-demand results in 20*-30 minutes minutes, enabling real-time determination of Flu A, Flu B and RSV infection, maximising clinical decision making. Xpert® Xpress Flu/RSV is the only test on the market developed with 27 primer/probe sets across 6 unique & independent targets to ensure optimum coverage and to anticipate seasonal antigenic shift and drift.
GeneXpert® - a better way:
- Implement prompt infection control measures
- Prevent avoidable ward closures
- Enable effective use of side rooms
- Improve patient flow
- Largest menu enables consolidation on a single platform, including Norovirus, CPE & C. difficile
Attending Infection Prevention 2019? Don’t miss the Cepheid Symposium:
POCT Flu Service, and the Impact on Infection Control and Treatment | Monday 23 September | 8:30-9:00am
Dr. John Boyes – Gloucestershire Hospitals NHS Foundation Trust
CE-IVD. In Vitro Diagnostic Medical Device. Not all products available in all countries.
With early assay termination (EAT) for positive Flu or for positive RSV only. Reporting negatives and combined Flu and RSV results in 30 minutes.
